CONCENTRA MANAGED CARE INC
SC 13D/A, 1999-07-07
SPECIALTY OUTPATIENT FACILITIES, NEC
Previous: VIDATRON ENTERTAINMENT GROUP INC, F-1/A, 1999-07-07
Next: BLUESTONE SOFTWARE INC, 8-A12G, 1999-07-07



CUSIP NO.  20589T-10-3                                         Page 1 of 6 Pages


                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D
                                 (Rule 13d-101)

             INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
            TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
                                  RULE 13d-2(a)

                               (Amendment No. 3)1 [FN]

                          Concentra Managed Care, Inc.
                                (Name of Issuer)

                          Common Stock, $.01 par value
                         (Title of Class of Securities)

                                   20589T-10-3
                                 (CUSIP Number)

Welsh, Carson, Anderson                      Robert A. Schwed, Esq.
  & Stowe VIII, L.P.,                        Reboul, MacMurray, Hewitt,
320 Park Avenue, Suite 2500                  Maynard & Kristol
New York, New York  10022                    45 Rockefeller Plaza
Attention:  Laura VanBuren                   New York, New York  10111
Tel. (212) 893-9500                          Tel. (212) 841-5700
                  (Name, Address and Telephone Number of Person
                Authorized to Receive Notices and Communications)

                                  July 2, 1999
             (Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d- 1(e), 13d-1(f) or 13d-1(g), check the following
box [ ].

- --------
[FN]     1The  remainder  of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page. The information required on
the remainder of this cover page shall not be deemed to be "filed" for the
purpose of Section 18 of the Securities Exchange  Act of 1934 or otherwise
subject to the liabilities of that section of the Act but shall be subject to
all other provisions of the Act.




<PAGE>


CUSIP NO.  20589T-10-3                                         Page 2 of 6 Pages

1)   Name of Reporting Person                     Welsh, Carson, Ander-
     I.R.S. Identification                        son & Stowe VIII, L.P.
     No. of Above Person
     (Entities Only)

2)   Check the Appropriate Box                            (a) [ ]
     if a Member of a Group                               (b) [ ]

3)   SEC Use Only

4)   Source of Funds                                Not Applicable


5)   Check if Disclosure of
     Legal Proceedings Is                           Not Applicable
     Required Pursuant to
     Items 2(d) or 2(e)

6)   Citizenship or Place
     of Organization                                Delaware

Number of                    7)   Sole Voting     7,046,127 shares of
Shares Beneficially               Power           Common Stock
Owned by Each                                     (including shares
Reporting Person                                  issuable upon
With                                              conversion of
                                                  Convertible Notes)
                             8)   Shared Voting
                                  Power                -0-

                             9)   Sole Disposi-   7,046,127 shares of
                                  tive Power      Common Stock
                                                  (including shares
                                                  issuable upon
                                                  conversion of
                                                  Convertible Notes)
                             10)  Shared Dis-
                                  positive Power       -0-

11)  Aggregate Amount Beneficially                7,046,127 shares of
     Owned by Each Reporting Person               Common Stock
                                                  (including shares
                                                  issuable upon
                                                  conversion of
                                                  Convertible Notes)
12)  Check if the Aggregate
     Amount in Row (11)
     Excludes Certain Shares






<PAGE>


CUSIP NO.  20589T-10-3                                         Page 3 of 6 Pages

13)  Percent of Class
     Represented by                               14.6%
     Amount in Row (11)

14)  Type of Reporting
     Person                                       PN




<PAGE>


CUSIP NO.  20589T-10-3                                         Page 4 of 6 Pages


                         Amendment No. 3 to Schedule 13D

          Reference is hereby made to the  statement on Schedule 13D  originally
filed with the Securities and Exchange  Commission (the "Commission") on October
30, 1998,  Amendment No. 1 thereto filed on January 12, 1999 and Amendment No. 2
thereto  filed on March 18,  1999 (as so amended,  the  "Schedule  13D").  Terms
defined in the Schedule 13D are used herein as so defined.

          The Schedule 13D is hereby amended as follows:

Item 2.   Identity and Background.

          Item 2 is hereby  amended by adding  Rudolph E. Rupert and Jonathan M.
Rather as Managing Members of VIII Associates.

Item 5.   Interest in Securities of the Issuer.

          Item 5 is hereby  amended  and  restated  to read in its  entirety  as
follows:

          The following  information is based on a total of 47,294,074 shares of
Common  Stock  outstanding  as of March 15,  1999,  as reported in the  Issuer's
Report on Form 10-K for the  fiscal  year ended  December  31,  1998,  and gives
effect to the conversion of all Convertible Notes held by the Reporting Person:

          (a)

          WCAS VIII and VIII Associates

          WCAS VIII owns  7,046,127  shares of Common  Stock,  or  approximately
     14.6% of the Common  Stock  outstanding.  VIII  Associates,  as the general
     partner  of WCAS VIII,  may be deemed to  beneficially  own the  securities
     owned by WCAS VIII.




<PAGE>


CUSIP NO.  20589T-10-3                                         Page 5 of 6 Pages



                       Managing Members of VIII Associates

          (i)Patrick J. Welsh owns 15,505  shares of Common Stock,  or less than
     0.1% of the Common Stock outstanding.

          (ii)Russell  L. Carson owns 600 shares of Common  Stock,  or less than
     0.1% of the Common Stock outstanding.

          (iii)  Bruce K.  Anderson  owns  100,000  shares of Common  Stock,  or
     approximately 0.2% of the Common Stock outstanding.

          (iv) Andrew M. Paul owns 2,500  shares of Common  Stock,  or less than
     0.1% of the Common Stock outstanding.

          (v) Thomas E.  McInerney  owns 11,801 shares of Common Stock,  or less
     than 0.1% of the Common Stock outstanding.

          (vi) Paul B. Queally owns 3,034 shares of Common  Stock,  or less than
     0.1% of the Common Stock outstanding.

          (b) The managing members of VIII Associates may be deemed to share the
power to vote or direct the  voting of and to dispose or direct the  disposition
of the Common  Stock owned by WCAS VIII.  Each of the  managing  members of VIII
Associates  disclaims  beneficial  ownership of all shares of Common Stock other
than the shares he or she owns  directly or by virtue of his or her indirect pro
rata interest,  as a managing  member of VIII  Partners,  in the shares owned by
WCAS VIII.

          (c) On July 2,  1999,  WCAS VIII sold an  aggregate  22,500  shares of
Common  Stock in open  market  transactions,  at an average  price of $14.68 per
share.  On July 6, 1999,  WCAS VIII sold an  aggregate  67,500  shares of Common
Stock in open  market  transactions,  at an  average  price of $14.58 per share.
These  dispositions  are not related to WCAS VIII's support of the  transactions
contemplated  by the  Merger  Agreement  described  in  Amendment  No.  2 to the
Schedule 13D.

          (d) Except as described in this statement,  no person has the power to
direct the  receipt of  dividends  on or the  proceeds of sales of the shares of
Common Stock owned by WCAS VIII.

          (e) Not applicable.





<PAGE>


CUSIP NO.  20589T-10-3                                         Page 6 of 6 Pages

                                    Signature

          After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information  set forth in this statement is true,  complete and
correct.

Dated: July 6, 1999


                                    WELSH, CARSON, ANDERSON & STOWE VIII, L.P.
                                    By:  WCAS VIII Associates, LLC, General
                                    Partner


                                    By:  /s/ Paul B. Queally
                                         Managing Member




<PAGE>




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission